A Pilot Study of Additional Chinese Formula for Concurrent Chemoradiotherapy in Oral Cavity Cancer Patients
Status:
Completed
Trial end date:
2020-12-25
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to learn about the clinical efficacy of
San-Zhong-Kui-Jian-Tang (SZKJT), a formula of Chinese medicine in head and neck cancer
patients receiving concurrent chemoradiotherapy (CCRT) treatments. The main questions it aims
to answer are:
- Can SZKJT improve the completion rate of CCRT?
- Can SZKJT reduce the adverse effects of CCRT?
- How SZKJT affect the quality of life in the patients receiving CCRT
- How about the safety of using SZKJT in the patients receiving CCRT
Participants will be asked to:
- take SZKJT for 9 weeks during the whole CCRT course
- take questionnaires of quality of life